Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis

Gunnar Tomasson; Peter A. Merkel

doi:10.7326/L14-5015-2

Letters |5 August 2014

Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis

Gunnar Tomasson, MD; Peter A. Merkel, MD, MPH

Article, Author, and Disclosure Information

IN RESPONSE:

As our article states, 19% of patients with GCA were receiving statins when this condition was diagnosed and 28% were receiving aspirin. Regarding the possible association between treatment with statins, aspirin, or both and treatment with glucocorticoids, we emphasize that treatment with glucocorticoids was embedded in our definition of GCA exposure. Furthermore, in our study cohort, only 34 patients received a statin (1.0%) and 128 received aspirin (3.6%) for the first time in the month before and the month after diagnosis of GCA was established. Therefore, our data sources do not allow assessment of the efficacy of these medications on cardiovascular outcomes in this study population.

FULL TEXT

PDF

Not Available

Letters |5 August 2014

Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

Letters |5 August 2014

Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis

See Also

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.